Updates of Genomics and Proteomics of Parathyroid Carcinoma

Parathyroid carcinoma is a rare disease that needs an additional diagnostic tool and wide therapeutic options. The genomics and proteomics approach may help to find the tools to improve the prognosis of the disease by early detection and metastatic control. The findings from genomics were mainly <...

Full description

Bibliographic Details
Main Author: Sung Hye Kong
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Endocrines
Subjects:
Online Access:https://www.mdpi.com/2673-396X/3/4/61
_version_ 1797459903266160640
author Sung Hye Kong
author_facet Sung Hye Kong
author_sort Sung Hye Kong
collection DOAJ
description Parathyroid carcinoma is a rare disease that needs an additional diagnostic tool and wide therapeutic options. The genomics and proteomics approach may help to find the tools to improve the prognosis of the disease by early detection and metastatic control. The findings from genomics were mainly <i>CDC73</i>, <i>PRUNE2</i>, <i>CCND1</i>, and genes related to PI3K/AKT/mTOR and Wnt pathways. <i>CDC73</i>, <i>PRUNE2</i>, and <i>CCND1</i> were closely related to each other, and <i>PRUNE2</i> and <i>CCND1</i> genes are related to expression levels of parafibromin protein, which may aid in supporting the definite diagnosis of the disease. PI3K/AKT/mTOR and Wnt pathways could be a potential therapeutic target for the disease, which needs further basket trials to prove the concept. In this review, current findings from genomics and proteomics studies in parathyroid carcinoma were reviewed.
first_indexed 2024-03-09T16:57:34Z
format Article
id doaj.art-50e9f082742b4c6aa5c518b353073fbf
institution Directory Open Access Journal
issn 2673-396X
language English
last_indexed 2024-03-09T16:57:34Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Endocrines
spelling doaj.art-50e9f082742b4c6aa5c518b353073fbf2023-11-24T14:33:29ZengMDPI AGEndocrines2673-396X2022-11-013474575210.3390/endocrines3040061Updates of Genomics and Proteomics of Parathyroid CarcinomaSung Hye Kong0Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Republic of KoreaParathyroid carcinoma is a rare disease that needs an additional diagnostic tool and wide therapeutic options. The genomics and proteomics approach may help to find the tools to improve the prognosis of the disease by early detection and metastatic control. The findings from genomics were mainly <i>CDC73</i>, <i>PRUNE2</i>, <i>CCND1</i>, and genes related to PI3K/AKT/mTOR and Wnt pathways. <i>CDC73</i>, <i>PRUNE2</i>, and <i>CCND1</i> were closely related to each other, and <i>PRUNE2</i> and <i>CCND1</i> genes are related to expression levels of parafibromin protein, which may aid in supporting the definite diagnosis of the disease. PI3K/AKT/mTOR and Wnt pathways could be a potential therapeutic target for the disease, which needs further basket trials to prove the concept. In this review, current findings from genomics and proteomics studies in parathyroid carcinoma were reviewed.https://www.mdpi.com/2673-396X/3/4/61parathyroidcancergenomicsproteomics
spellingShingle Sung Hye Kong
Updates of Genomics and Proteomics of Parathyroid Carcinoma
Endocrines
parathyroid
cancer
genomics
proteomics
title Updates of Genomics and Proteomics of Parathyroid Carcinoma
title_full Updates of Genomics and Proteomics of Parathyroid Carcinoma
title_fullStr Updates of Genomics and Proteomics of Parathyroid Carcinoma
title_full_unstemmed Updates of Genomics and Proteomics of Parathyroid Carcinoma
title_short Updates of Genomics and Proteomics of Parathyroid Carcinoma
title_sort updates of genomics and proteomics of parathyroid carcinoma
topic parathyroid
cancer
genomics
proteomics
url https://www.mdpi.com/2673-396X/3/4/61
work_keys_str_mv AT sunghyekong updatesofgenomicsandproteomicsofparathyroidcarcinoma